Skip to main content
. 2022 Oct 3;11(19):5859. doi: 10.3390/jcm11195859

Table 3.

Tacrolimus- vs. cyclosporine-treated group: baseline characteristics.

Overall
N = 128 (100)
Tacrolimus
N = 42 (33)
Cyclosporine
N = 86 (67)
p-value
Baseline characteristics
Age, years 53 [43, 60] 55 [42, 61] 52 [44, 60] 0.401
M, n (%) 82 (64) 25 (60) 57 (66) 0.502
F, n (%) 46 (36) 17 (40) 29 (34)
BMI, kg/m2 23 [20, 27] 24 [20, 27] 23 [21, 27] 0.999
Corticosteroids, n (%) 72 (56) 18 (43) 54 (63) 0.040
O2 therapy, n (%) 115 (90) 36 (86) 79 (92) 0.350
Diabetes, n (%) 23 (18) 10 (24) 13 (15) 0.230
Chronic renal disease, n (%) 2 (2) 0 (0) 2 (2) 0.999
Oto score 3 [1, 5] 3 [2, 5] 3 [1, 5] 0.201
LAS 36 [33, 40] 38 [34, 45] 35 [33, 39] <0.001
Underlying diseases *
Septic, n (%) 29 (23) 9 (21) 20 (23) 0.010
Interstitial, n (%) 65 (51) 26 (62) 39 (45)
Obstructive, n (%) 23 (18) 7 (17) 16 (19)
Others, n (%) 11 (9) 0 (0) 11 (13)
Previous colonization
Recipient-related, n (%) 41 (32) 12 (29) 29 (34) 0.600
None, n (%) 87 (68) 30 (71) 57 (66)
Provenience
Hospital, n (%) 8 (6) 4 (10) 4 (5)
Home, n (%) 120 (94) 38 (90) 82 (95) 0.400

Data are expressed median [I-III quartile] for continuous variables and absolute numbers (percentage) for categorical ones. * Septic: cystic fibrosis, bronchiectasis; Interstitial: idiopathic pulmonary fibrosis, allergic extrinsic alveolitis, non-specific interstitial pneumonia, fibrosing emphysema, lymphocytic interstitial pneumonia, respiratory bronchiolitis interstitial lung; Obstructive: chronic obstructive pulmonary disease, emphysema; Others: idiopathic pulmonary hypertension, veno-occlusive disease, connective tissue disease, α1-anti-tripsin deficiency, lymphangioleiomyomatosis, histiocytosis, sarcoidosis, graft versus host disease. Abbreviations: BMI, body mass index; F, female; LAS, lung allocation score; LT, lung transplantation; M, male; n, number.